Ultrasound study of bleeding risk after EMG in patients on blood thinners
Part of Brain & nervous system clinical trials.
This study uses ultrasound to check for bleeding after a needle EMG (a test for nerve and muscle problems) in people taking direct oral anticoagulants (blood thinners). It aims to see if it's safe to have the test while on this medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be taking a standard dose of a direct oral anticoagulant (like apixaban, rivaroxaban, edoxaban, or dabigatran) daily.
- You cannot be taking any other blood thinners (like aspirin, clopidogrel, ticagrelor, heparin, or another direct oral anticoagulant).
- You must be willing and able to follow the study procedures.
- You must sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
This trial looks at how often bleeding happens after an upper scope (EGD) or colonoscopy in people who keep taking blood-thinning medicines during the procedure. The results may help doctors choose safer prep plans to lower bleeding risk.
This study looks at how people doing well on certain blood thinners do when they have a stroke or bleeding while taking them. It will measure medication levels in your blood to understand stroke severity and recovery in the short and long term.
This trial looks at whether lower muscle mass in people aged 70 or older is linked to a higher risk of serious bleeding while taking the blood thinners Apixaban or Rivaroxaban. The goal is to help doctors better identify who might be at risk.
This study looks at how often bleeding happens in people with chronic kidney disease who are taking blood thinners (anticoagulants) for conditions like blood clots, mechanical heart valves, or atrial fibrillation (an irregular heartbeat). It aims to identify risk factors for bleeding to help doctors manage treatment more safely.
Hear when a new EMG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.